Skip to main content

Table 2 Description of medical context and infectious disease

From: Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis

Characteristics

DAP (N = 28)

VAN (N = 44)

p

Reason for ICU admission

  

.004

 Cardiac surgery, n (%)

15 (53.6)

26 (59.1)

 Vascular surgery, n (%)

2 (7.1)

14 (31.8)

 Interventional cardiology or short-term mechanical circulatory support, n (%)

9 (32.1)

4 (9.4)

 Mediastinitis, n (%)

2 (7.1)

0 (0)

Primary infectious disease

  

.045

 Infective endocarditis, n (%)

8 (28.6)

15 (34.1)

 Vascular graft infection, n (%)

2 (7.1)

12 (27.3)

 VAD infection, n (%)

4 (14.3)

0 (0)

 Surgical site infection, n (%)

5 (17.9)

6 (13.6)

 Catheter-related infection, n (%)

5 (17.9)

4 (9.1)

 Miscellaneous, n (%)

4 (14.3)

7 (15.9)

Microbiological identification

  

.002

 MSSA, n (%)

7 (25.0)

4 (9.1)

 MRSA, n (%)

4 (14.3)

3 (6.8)

 CNS, n (%)

13 (46.4)

9 (20.5)

 Enterococcus, n (%)

1 (3.6)

4 (9.1)

 Other Gram-positive cocci, n (%)

1 (3.6)

6 (13.6)

 Other strains or non-documented, n (%)

2 (7.1)

18 (40.1)

  1. P-values for Fisher exact test. DAP daptomycin, VAN vancomycin, ICU intensive care unit, VAD ventricular assist device, MSSA methicillin-susceptible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CNS coagulase negative staphylococci